Susquehanna International Group, LLP Eiger Bio Pharmaceuticals, Inc. Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.21 - $0.43 $801 - $1,641	3,818 Added 17.6%	25,513 $5,000
Q3 2023 Nov 14, 2023	SELL	$0.28 - $0.93 $5,521 - $18,340	-19,721 Reduced 47.62%	21,695 $6,000
Q2 2023 Aug 11, 2023	BUY	$0.55 - $1.26 $12,128 - $27,785	22,052 Added 113.88%	41,416 $28,000
Q1 2023 May 16, 2023	BUY	$0.89 - $2.52 $8,032 - $22,743	9,025 Added 87.29%	19,364 $17,000
Q4 2022 Feb 14, 2023	SELL	$1.02 - $7.48 $2,068 - $15,169	-2,028 Reduced 16.4%	10,339 $12,000
Q3 2022 Nov 14, 2022	SELL	$6.04 - $9.66 $39,205 - $62,703	-6,491 Reduced 34.42%	12,367 $93,000
Q2 2022 Aug 15, 2022	SELL	$4.99 - $8.96 $144,964 - $260,296	-29,051 Reduced 60.64%	18,858 $119,000
Q4 2021 Feb 14, 2022	BUY	$5.12 - $8.19 $599 - $958	117 Added 0.24%	47,909 $249,000
Q3 2021 Nov 15, 2021	BUY	$6.68 - $9.1 $58,376 - $79,524	8,739 Added 22.38%	47,792 $319,000
Q2 2021 Aug 11, 2021	SELL	$7.82 - $9.23 $302,579 - $357,136	-38,693 Reduced 49.77%	39,053 $333,000
Q3 2020 Nov 16, 2020	BUY	$7.96 - $12.42 $618,858 - $965,605	77,746 New	77,746 $633,000
Q2 2020 Aug 14, 2020	SELL	$5.4 - $13.37 $95,202 - $235,713	-17,630 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$4.91 - $14.7 $17,150 - $51,347	3,493 Added 24.71%	17,630 $120,000
Q3 2019 Nov 14, 2019	SELL	$9.59 - $12.0 $240,124 - $300,468	-25,039 Reduced 63.91%	14,137 $145,000
Q2 2019 Aug 16, 2019	BUY	$9.54 - $14.96 $19,537 - $30,638	2,048 Added 5.52%	39,176 $415,000
Q2 2019 Aug 14, 2019	SELL	$9.54 - $14.96 $513,309 - $804,937	-53,806 Reduced 59.17%	37,128 $394,000
Q1 2019 May 15, 2019	BUY	$10.31 - $14.38 $453,361 - $632,331	43,973 Added 93.64%	90,934 $1.27 Million
Q4 2018 Feb 14, 2019	BUY	$8.63 - $12.4 $405,273 - $582,316	46,961 New	46,961 $477,000

Others Institutions Holding EIGR

# of Institutions

Shares Held

748K

Call Options Held

Put Options Held

View Full List

About Eiger BioPharmaceuticals, Inc.

Ticker EIGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,966,800
Market Cap $418M
Description
Eiger BioPharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of targeted therapies for rare and ultra-rare diseases in the United States and internationally. Its lead product candidate is Lonafarnib, an orally bioavailable, small molecule, which is in Phase III clinical trials to ...

More about EIGR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account